GENYX Trademark

Trademark Overview

On Friday, May 7, 2021, a trademark application was filed for GENYX with the United States Patent and Trademark Office. The USPTO has given the GENYX trademark a serial number of 79312816. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by MTPCR Pty Ltd. The GENYX trademark is filed in the Pharmaceutical Products category with the following description:

Clinical diagnostic reagents for medical and veterinary use, including in vitro diagnostic reagents
genyx

General Information

Serial Number79312816
Word MarkGENYX
Filing DateFriday, May 7, 2021
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6897506
Registration DateTuesday, November 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements

Goods and ServicesClinical diagnostic reagents for medical and veterinary use, including in vitro diagnostic reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMTPCR Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameMTPCR Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameMTPCR Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Wednesday, March 29, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 9, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 8, 2023FINAL DISPOSITION PROCESSED
Wednesday, February 15, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 7, 2022REFUSAL PROCESSED BY IB
Tuesday, February 15, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 15, 2022REFUSAL PROCESSED BY MPU
Tuesday, January 25, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 24, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 12, 2022ASSIGNED TO EXAMINER
Tuesday, June 15, 2021APPLICATION FILING RECEIPT MAILED
Friday, June 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 10, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

genyx reagents diagnostic vitro including medical clinical veterinary